Children's and Young People Phoenix Service to NHS Somerset Integrated Care Board

Open

Value

£4,000,000

Classifications

  • Health services
  • Counselling services

Tags

  • tender

Submission Deadline

4 weeks from now

Published

4 days ago

Description

NHS Somerset Integrated Care board (ICB) is seeking to secure a provider who has the capability and capacity to deliver a Support Service for Children, Young People and Families who have been affected by child sexual abuse (CSA). 
This will cover children and young people aged 0-18 years, who are living in Somerset or who have a registered Somerset GP.
The service will focus on providing support for CYP aged 0-18 years who have experienced CSA, including those who may fall outside the threshold for admission to specialist mental health services and/or other specialist services. The service will work collaboratively with specialist services to ensure comprehensive support and continuity of care for these individuals.
Service Objectives: 
•	To deliver age-appropriate, high-quality and effective services for CYP, their families and carers addressing the psychological and emotional impact of CSA as early as possible.
•	To provide individualised support focused on the unique needs and contexts of each C/YP ensuring services are tailored to their presenting issues.
•	To empower CYP and their families to move forward positively in their lives by promoting resilience and recovery rather than focusing solely on the events of the abuse.
•	To minimise the long-term negative impact of CSA on the mental health, emotional wellbeing and overall quality of life for CYP and their families in Somerset.
The service will: 
•	Deliver a range of effective and evidence-based advice, information, talking, therapeutic and creative interventions.
•	Deliver a consistent and timely support service to the multi-agency workforce working to support children who have experienced sexual abuse, enabling staff from other services to safely and effectively 'identify, hold and respond'.
•	Provide appropriately trained staff who have an expertise in engaging and building relationships with CYP and their families and have the skills to assess and understand the barriers CYP may face, involving other agencies and professionals as appropriate.
•	Provide staff who are friendly, well-trained professionals, capable of offering advice, counselling and other appropriate interventions to support CYP.
•	Be offered in a safe, comfortable, confidential and non-judgemental environment.
•	Develop and maintain effective and efficient local and national networks to build a holistic, integrated and seamless package of support for CYP, their families and carers.
TUPE is likely to be applicable, further details can be found in the procurement documentation.
The contract term will be for 6 years with an optional extension of any period up to a further 2 years.
The contract value is £380,436 per annum giving a contract value of £2,282,616 for the initial contract period and £3,043,488 if the full extension period is adopted.
The new service will commence on the 1st October 2025
Commissioners reserve the right to add funding to the contract over its duration to accommodate service development measures or initiatives, up to an equivalent value of the original contract.  For the avoidance of doubt, this would mean an annual contract value of, for example, £500k per annum and a consequent increase in the overall contract value.
This exercise is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioner.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

Provision of Community Pharmacy RSV and Pertussis Vaccination Enhanced Service

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of NHS England (NHSE) (The Commissioner) would like to notify the market of an opportunity to provide Community Pharmacy RSV and Pertussis Vaccination Enhanced Service within the Midlands Region.<br/><br/>Respiratory Syncytial Virus (RSV) is a virus that for most people causes a mild respiratory illness, but can be more serious for those, including older adults and infants, who are at risk of more severe respiratory disease. Following the Joint Committee on Vaccination and Immunisation (JCVI) recommendation, the Commissioner will commission from September 2024:<br/><br/>• an adult programme (predominately to be commissioned through general practice); and<br/>• an infant programme provided as vaccination during pregnancy (predominantly to be commissioned through NHS Trusts).<br/><br/>In addition, where there are areas of identified additional need, the Commissioner will commission community pharmacy to provide additional capacity and increased access to supplement the core provision of these two programmes. <br/><br/>Pertussis (whooping cough) is a respiratory disease that is caused by the Bordetella pertussis bacterium. Pertussis can cause serious and life-threatening complications including pneumonia, difficulty in breathing (apnoea) and seizures. Pertussis most commonly affects infants, and very young infants are at highest risk of serious complications, of needing admission to hospital or of dying.<br/><br/>Pregnant women are eligible for the Pertussis vaccine from 16 weeks pregnancy, although the optimal window for protection is between 20 and 32 weeks of pregnancy. Commissioners have commissioned general practice and NHS trusts to deliver the Pertussis vaccination programme for pregnant women.<br/><br/>In addition, where there are areas of identified additional need, the Commissioner will commission community pharmacy to provide the Pertussis vaccination programme opportunistically to pregnant women to supplement the core service provision.<br/><br/>This Procurement Process is for the service provision in the Midlands Region where up to 66 sites from multiple potential Suppliers will be selected to provide the Services from May 2025. The 66 successful sites will be in three ICBs within the Midlands Region, with 22 sites allocated per lot to allow the Commissioner to ensure an even geographical spread. Should fewer than 22 sites be awarded to a Lot, up to 4 additional sites may be awarded under alternative Lot(s) at the Commissioners discretion. The ICB's included in this procurement are NHS Black Country ICB, NHS Leicester, Leicestershire, & Rutland ICB & NHS Birmingham and Solihull ICB.<br/><br/>The value of the service provision resulting from this Procurement Process will be an Item of Service (IoS) fee of £9.58 for the administration of each RSV and pertussis vaccine to each eligible patient.<br/><br/>The number of eligible patients, and therefore the likely activity level, could change as a result of factors beyond the Commissioner’s control such as an increase or decrease in population of the local area, closure or merger of other nearby NHS health organisations, or patient.<br/><br/>Services will commence in May 2025 and will continue until 31st March 2027, with an option for the Commissioner to extend for 24 months until 31 March 2029.<br/><br/>Please note the deadline for responses to the ITT is 12:00PM (Mid-Day) on Friday 14th March 2025.

NHS England

Published 4 hours ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline active

Publish
Bid
Evaluate
Award
Complete